Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced the appointment of two pharmaceutical veterans to its executive leadership team: Sesha Neervannan to the position of Chief Operating Officer (COO), and Leo Greenstein to the position of Chief Financial Officer (CFO). As part of its leadership, Sesha and Leo will help guide Tarsus Pharmaceuticals’ corporate and product development, leveraging their proven knowledge, capabilities, and leadership skills to help Tarsus achieve its objectives.
Visionary Ventures
Life sciences venture capital fund investing in ophthalmology and medical aesthetics.
